×
About 3,910 results

ALLMedicine™ Antiphospholipid Syndrome Center

Research & Reviews  1,455 results

Coronavirus-disease-2019-induced antiphospholipid-like syndrome: a case report.
https://doi.org/10.1186/s13256-021-02966-4 10.1016/S2213-2600(20)30060-6 10.1016/S0140-6736(20)31042-4 10.1186/s13054-019-2683-3 10.1002/jmv.25702 10.1016/j.thromres.2015.08.019 10.1111/jth.14768 10.1182/blood-2017-10-804096 10.1002/art.41425 10.1056/NEJMra1705454 10.1016/S2352-3026(20)30145-9 10.1007/s11427-020-1643-8 10.1007/s12098-020-03263-6 10.1097/SLA.0000000000003925
Journal of Medical Case Reports; Bahramnezhad F, Ghorbani B et. al.

Jul 30th, 2021 - This paper describes a case of antiphospholipid syndrome-like condition caused by coronavirus disease 2019. The medical community still faces many diagnostic and therapeutic challenges vis-à-vis coronavirus disease 2019. Ultimately, coronavirus di...

Chronic oxcarbazepine intoxication in a patient with primary antiphospholipid syndrome ...
https://doi.org/10.1111/jcpt.13504
Journal of Clinical Pharmacy and Therapeutics; Dirim AB, Mirioglu S et. al.

Jul 30th, 2021 - Oxcarbazepine (OXC) is an antiepileptic drug. Patients suffering from chronic kidney disease with an estimated glomerular filtration rate below 30 ml/min/1.73 m2 require dose adjustments for OXC. A 31-year-old man was admitted with a history of di...

Avoiding misclassification of thrombotic primary antiphospholipid syndrome as systemic ...
https://doi.org/10.1177/09612033211033978
Lupus Signorelli F, Balbi GGM et. al.

Jul 23rd, 2021 - Systemic lupus erythematosus (SLE) and Primary Antiphospholipid Syndrome (PAPS) overlap clinical and immunological features. Therefore, misclassification of PAPS patients as SLE is a concern. The ACR/EULAR 2019 SLE classification has never been st...

Effect of statins on the prevention of recurrent thrombosis in thrombotic antiphospholi...
https://doi.org/10.1093/rheumatology/keab410
Rheumatology (Oxford, England); Kwon OC, Park YB et. al.

Jul 22nd, 2021 - To assess the effect of statins on the prevention of recurrent thrombosis in patients with thrombotic antiphospholipid syndrome (APS). This retrospective cohort study included 184 patients with thrombotic APS. The effect of statins on recurrent th...

Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of i...
https://doi.org/10.1177/09612033211033988
Lupus Menet J, Agrinier N et. al.

Jul 22nd, 2021 - Antiphospholipid syndrome (APS) is characterized by several clinical manifestations such as venous and arterial thrombosis associated with persistent antiphospholipid antibodies (aPL). Several studies confirmed that retinal vein occlusion was the ...

see more →

Guidelines  4 results

First Latin American clinical practice guidelines for the treatment of systemic lupus e...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225798
Annals of the Rheumatic Diseases; Pons-Estel BA, Bonfa E et. al.

Jul 27th, 2018 - Systemic lupus erythematosus (SLE), a complex and heterogeneous autoimmune disease, represents a significant challenge for both diagnosis and treatment. Patients with SLE in Latin America face special problems that should be considered when therap...

European evidence-based recommendations for diagnosis and treatment of paediatric antip...
https://doi.org/10.1136/annrheumdis-2016-211001
Annals of the Rheumatic Diseases; Groot N, de Graeff N et. al.

May 6th, 2017 - Antiphospholipid syndrome (APS) is rare in children, and evidence-based guidelines are sparse. Consequently, management is mostly based on observational studies and physician's experience, and treatment regimens differ widely. The Single Hub and A...

Practice Bulletin No. 132: Antiphospholipid syndrome.
https://doi.org/10.1097/01.AOG.0000423816.39542.0f
Obstetrics and Gynecology;

Nov 22nd, 2012 - Antiphospholipid syndrome (APS) is an autoimmune disorder defined by the presence of characteristic clinical features and specified levels of circulating antiphospholipid antibodies (Box 1 and Box 2). Diagnosis requires that at least one clinical ...

ACOG Practice Bulletin No. 118: antiphospholipid syndrome.
https://doi.org/10.1097/AOG.0b013e31820a61f9
Obstetrics and Gynecology;

Dec 22nd, 2010 - ACOG Practice Bulletin No. 118: antiphospholipid syndrome.|2010||

see more →

Clinicaltrials.gov  20 results

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
https://clinicaltrials.gov/ct2/show/NCT00198068

Jan 18th, 2020 - Thrombosis and pregnancy loss are common features of systemic lupus erythematosus (SLE), particularly in the presence of antiphospholipid (aPL) antibodies. The in vivo mechanisms by which aPL antibodies lead to vascular events and, specifically, t...

Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.
https://clinicaltrials.gov/ct2/show/NCT00180817

Mar 21st, 2019 - The association between APA and thrombosis is well documented. Both LA and ACA are often detected in individuals with SLE but there is no prospective data on the risk of thrombosis in women who present with recurrent miscarriages in association wi...

Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss
https://clinicaltrials.gov/ct2/show/NCT00180778

Mar 13th, 2019 - Over the last decade, the APS has emerged as most important treatable cause of recurrent miscarriages. The pathogenesis of fetal loss in this condition is still remains obscure. Despite the success of aspirin + heparin treatment, some pregnant wom...

Multi-organ Screening for Asymptomatic Ischaemia in Antiphospholipid Syndrome
https://clinicaltrials.gov/ct2/show/NCT03348306

Oct 10th, 2018 - Introduction AntiPhospholipid antibody Syndrome (APS) is an acquired autoimmune disorder defined by the presence of persistent thrombosis or obstetric manifestations together with the presence of persistent antiphospholipid antibodies (aPL). Patie...

RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome
https://clinicaltrials.gov/ct2/show/NCT03684564

Sep 25th, 2018 - RISAPS: Rivaroxaban versus warfarin for stroke patients with antiphospholipid syndrome, with or without SLE: a randomised, controlled, phase II/III, non-inferiority trial 140 patients will be randomised at a 1:1 to receive either rivaroxaban 15mg ...

see more →

News  81 results

Managing Diffuse Peripheral Ischemia in Antiphospholipid Syndrome: Anticoagulation, Immunosuppression, or Vasodilation?
https://www.medscape.com/viewarticle/948988

Apr 14th, 2021 - This article originally appeared on Hospital for Special Surgery's website. Case Report A 39-year-old man with a history of well-controlled type 1 diabetes (T1D) since childhood and migraine presented with 1 week of pain and cyanosis of the finger...

Managing Diffuse Peripheral Ischemia in Antiphospholipid Syndrome: Anticoagulation, Immunosuppression, or Vasodilation?
https://www.medscape.com/viewarticle/948988?src=sapfe

Apr 14th, 2021 - This article originally appeared on Hospital for Special Surgery's website. Case Report A 39-year-old man with a history of well-controlled type 1 diabetes (T1D) since childhood and migraine presented with 1 week of pain and cyanosis of the finger...

COVID-19 Clotting May Be Linked With Antiphospholipid Antibodies
https://www.medscape.com/viewarticle/938529

Oct 6th, 2020 - (Reuters) - The excessive blood clotting seen in severe COVID-19 may in part be caused by the virus tricking the body into producing antiphospholipid antibodies, new research suggests. In a study of 64 COVID-19 patients published on Wednesday in C...

'Hypercoagulation,' Antiphospholipid Antibodies Seen in COVID-19
https://www.medscape.com/viewarticle/928653

Apr 14th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. COVID-19 infection may represent a "hypercoagulable" state, new research suggests. Researchers from China describe three patients admitted to the...

'Hypercoagulation,' Antiphospholipid Antibodies Seen in COVID-19
https://www.staging.medscape.com/viewarticle/928653

Apr 14th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. COVID-19 infection may represent a "hypercoagulable" state, new research suggests. Researchers from China describe three patients admitted to the...

see more →

Patient Education  4 results see all →